Join NCITA for a webinar which will provide an overview of the translation of Hyperpolarised ¹³C-MRI from preclinical to clinical cancer imaging.

Please register for the webinar through the Eventbrite link: https://www.eventbrite.co.uk/e/167050308971 

Who should attend:

Suitable for any researchers who are interested and would like to find out more about the translation of Hyperpolarised ¹³C-MRI from preclinical to clinical cancer imaging.

Why should I attend:

To hear an overview of the latest research in Hyperpolarised ¹³C-MRI, as well as the latest updates on clinical studies and technical advances across NCITA partner institutions.

Confirmed speakers and talks:

• • Chairs – Dr Ramona Woitek & Prof. Evis Sala, University of Cambridge
  • Imaging tumour metabolism (13C and 2H) – Prof. Kevin Brindle, University of Cambridge
  • Clinical metabolic imaging – Prof. Ferdia Gallagher, University of Cambridge
  • Developing methods for the acquisition and post-processing of hyperpolarised ¹³C data – Dr James Grist, University of Oxford
  • Numerical optimization in magnetic resonance imaging of metabolism – Vencel Somai , University of Cambridge
  • Quantifying Hyperpolarised ¹³C-MR: What’s the best metric? – Rafat Chowdhury, University College London
  • Imaging metabolic heterogeneity in breast cancer subtypes that are defined by their genomic profiles – Dr Susana Ros, University of Cambridge
  • Clinical hyperpolarised ¹³C-MRI in breast cancer – Dr Ramona Woitek, University of Cambridge
  • HP ¹³C MRI in renal cell carcinoma – Dr Stephan Ursprung, University of Cambridge
  • Imaging prostate cancer with hyperpolarised ¹³C-MRI: technical aspects – Dr Nikita Sushentsev, University of Cambridge
  • Hyperpolarised ¹³C-MRI of the prostate at UCL – Prof. Shonit Punwani, University College London